Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study
Clinical trial NCT06607302 · RECRUITING
Trial details
- NCT number
- NCT06607302
- Sponsor
- iOMEDICO AG
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-08
- Primary completion
- 2027-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.